Shuttle Pharmaceuticals Holdings Inc (SHPH)

$1.48 -0.04 (-2.63%)
Market Cap 2.29M
Revenue (ttm) 0.00
Net Income (ttm) -9.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 204,908
Avg Vol 480,516
Day's Range N/A - N/A
Shares Out 1.60M
Stochastic %K 16%
Beta -1.00
Analysts Strong Buy
Price Target N/A

Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HD...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 403 4212
Address:
401 Professional Drive, Suite 260, Gaithersburg, United States
SPARTANVI
SPARTANVI Jan. 15 at 9:15 PM
$IOTR above 3.5$ this goes hard 600k floater High CTB 303% 0 shortshares $MLEC $RAYA $SHPH
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 9:09 PM
$IOTR Good sympathy play with $SHPH Crazy ctb 600k float 🌋⏰️👇 $RAYA nice moves too
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 9:06 PM
$IOTR $SHPH $CGTL $CJMB $MLEC IOTR potential next Singapore ticker to go Has a nice gap up
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 9:02 PM
$IOTR Singapore based Low floater like $SHPH 600k float 302% CTB Bottom Could pull a crazy move Watching $CGTL $CJMB $MLEC
0 · Reply
lighthouse123
lighthouse123 Jan. 15 at 8:46 PM
$SHPH short shares available is actually 9000 according latest update
0 · Reply
lecorb
lecorb Jan. 15 at 8:38 PM
$SHPH 8-K 2026-01-12 In addition to her recent appointment as Chief Financial Officer of iSpecimen Inc., Ms. Liang currently serves as Chief Financial Officer of BlockchainK2 Corp., Goldhills Holding Ltd, Intact Gold Corp., Kincora Copper Limited, Transatlantic Mining Corp., and Ultra Brands Ltd. She also serves as both Chief Financial Officer and Director of Modern Plant Based Foods Inc. and Montego Resources Inc. In these roles, Ms. Liang has overseen consolidated financial reporting, ensured compliance with IFRS and US GAAP, and provided strategic guidance to executive teams and boards of directors. https://app.quotemedia.com/data/downloadFiling?webmasterId=500&ref=319699142&type=HTML&symbol=SHPH&cdn=67911917b8ee86ce6049a15ab5b4bf89&companyName=Shuttle+Pharmaceuticals+Holdings+Inc.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2026-01-12&_gl=1*7n7lts*_gcl_au*ODgzNzk0OTgwLjE3NjgxOTI1MDg.
0 · Reply
lecorb
lecorb Jan. 15 at 8:22 PM
$SHPH Last update : 12 minutes ago Time Since Last Change Timestamp (UTC) US:SHPH Short Shares Availability 13 minutes ago 2026-01-15 20:08:12.497 9,000 5 hours ago 2026-01-15 15:17:12.378 10,000 6 hours ago 2026-01-15 14:13:17.246 9,000 8 hours ago 2026-01-15 11:38:53.236 15,000 12 hours ago 2026-01-15 07:58:45.477 25,000 18 hours ago 2026-01-15 02:09:42.074 15,000 1 day ago 2026-01-14 20:09:11.609 20,000 1 day ago 2026-01-14 17:29:06.242 30,000 1 day ago 2026-01-14 16:56:41.21 35,000 1 day ago 2026-01-14 14:14:43.854 20,000
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 7:47 PM
$NCEW Crazy setup 500k floater Low floater going crazy today This one has similar Setup as $SHPH Watching $PTHL $GNPX $MLEC too
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 7:35 PM
$NCEW Dont sleep on this has the $SHPH looks
0 · Reply
anonAlb
anonAlb Jan. 15 at 7:32 PM
$NCEW this baby is definitely the next🔥🔥🔥🚀🚀🚀🚀🚀 $SHPH $MLEC $CJMB 🌙🌙🌙🌙🌙🌙🌙
0 · Reply
Latest News on SHPH
Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Jan 13, 2026, 4:00 PM EST - 2 days ago

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Shuttle Pharmaceuticals Acquires AI Health Platform

Nov 21, 2025, 9:30 AM EST - 7 weeks ago

Shuttle Pharmaceuticals Acquires AI Health Platform

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Nov 3, 2025, 7:00 AM EST - 2 months ago

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Oct 22, 2025, 10:00 AM EDT - 3 months ago

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Oct 22, 2025, 7:00 AM EDT - 3 months ago

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Oct 21, 2025, 5:55 PM EDT - 3 months ago

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

Oct 21, 2025, 4:05 PM EDT - 3 months ago

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

Shuttle Executes LOI with Molecule.ai

Oct 10, 2025, 10:20 AM EDT - 3 months ago

Shuttle Executes LOI with Molecule.ai

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Oct 9, 2025, 4:15 PM EDT - 3 months ago

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Aug 14, 2025, 4:05 PM EDT - 5 months ago

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Jun 24, 2025, 4:10 PM EDT - 7 months ago

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Jun 20, 2025, 3:55 PM EDT - 7 months ago

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

Jun 12, 2025, 12:00 PM EDT - 7 months ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

Jun 12, 2025, 8:30 AM EDT - 7 months ago

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Jun 4, 2025, 4:01 PM EDT - 8 months ago

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Shuttle Pharma Provides Corporate Update

May 15, 2025, 4:45 PM EDT - 8 months ago

Shuttle Pharma Provides Corporate Update

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

May 8, 2025, 4:01 PM EDT - 9 months ago

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Apr 21, 2025, 4:15 PM EDT - 9 months ago

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Apr 10, 2025, 4:01 PM EDT - 10 months ago

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Mar 13, 2025, 4:10 PM EDT - 11 months ago

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Mar 12, 2025, 9:24 AM EDT - 11 months ago

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Mar 12, 2025, 6:20 AM EDT - 11 months ago

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Feb 26, 2025, 10:45 AM EST - 11 months ago

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 7, 2025, 9:00 AM EST - 1 year ago

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Nov 26, 2024, 9:00 AM EST - 1 year ago

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Nov 13, 2024, 5:00 PM EST - 1 year ago

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 29, 2024, 9:05 PM EDT - 1 year ago

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Oct 28, 2024, 4:05 PM EDT - 1 year ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Sep 4, 2024, 4:15 PM EDT - 1 year ago

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Aug 26, 2024, 4:10 PM EDT - 1 year ago

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Aug 14, 2024, 4:10 PM EDT - 1 year ago

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Jul 19, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

Jun 18, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 22, 2024, 4:15 PM EDT - 1 year ago

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

Shuttle Pharma Provides First Quarter 2024 Corporate Update

May 14, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma Provides First Quarter 2024 Corporate Update

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 23, 2024, 4:15 PM EDT - 1 year ago

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Mar 22, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

Mar 5, 2024, 9:00 AM EST - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering

Feb 13, 2024, 8:00 AM EST - 2 years ago

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Jan 23, 2024, 4:30 PM EST - 2 years ago

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Jan 8, 2024, 9:00 AM EST - 2 years ago

Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

Dec 11, 2023, 9:00 AM EST - 2 years ago

Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023

Nov 30, 2023, 9:00 AM EST - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update

Nov 14, 2023, 9:00 AM EST - 2 years ago

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update

Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement

Oct 31, 2023, 9:00 AM EDT - 2 years ago

Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement

Shuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor Conference

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Shuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor Conference

Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

Sep 25, 2023, 9:00 AM EDT - 2 years ago

Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

Shuttle Pharma Participates in Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair

Sep 13, 2023, 9:00 AM EDT - 2 years ago

Shuttle Pharma Participates in Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair

SPARTANVI
SPARTANVI Jan. 15 at 9:15 PM
$IOTR above 3.5$ this goes hard 600k floater High CTB 303% 0 shortshares $MLEC $RAYA $SHPH
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 9:09 PM
$IOTR Good sympathy play with $SHPH Crazy ctb 600k float 🌋⏰️👇 $RAYA nice moves too
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 9:06 PM
$IOTR $SHPH $CGTL $CJMB $MLEC IOTR potential next Singapore ticker to go Has a nice gap up
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 9:02 PM
$IOTR Singapore based Low floater like $SHPH 600k float 302% CTB Bottom Could pull a crazy move Watching $CGTL $CJMB $MLEC
0 · Reply
lighthouse123
lighthouse123 Jan. 15 at 8:46 PM
$SHPH short shares available is actually 9000 according latest update
0 · Reply
lecorb
lecorb Jan. 15 at 8:38 PM
$SHPH 8-K 2026-01-12 In addition to her recent appointment as Chief Financial Officer of iSpecimen Inc., Ms. Liang currently serves as Chief Financial Officer of BlockchainK2 Corp., Goldhills Holding Ltd, Intact Gold Corp., Kincora Copper Limited, Transatlantic Mining Corp., and Ultra Brands Ltd. She also serves as both Chief Financial Officer and Director of Modern Plant Based Foods Inc. and Montego Resources Inc. In these roles, Ms. Liang has overseen consolidated financial reporting, ensured compliance with IFRS and US GAAP, and provided strategic guidance to executive teams and boards of directors. https://app.quotemedia.com/data/downloadFiling?webmasterId=500&ref=319699142&type=HTML&symbol=SHPH&cdn=67911917b8ee86ce6049a15ab5b4bf89&companyName=Shuttle+Pharmaceuticals+Holdings+Inc.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2026-01-12&_gl=1*7n7lts*_gcl_au*ODgzNzk0OTgwLjE3NjgxOTI1MDg.
0 · Reply
lecorb
lecorb Jan. 15 at 8:22 PM
$SHPH Last update : 12 minutes ago Time Since Last Change Timestamp (UTC) US:SHPH Short Shares Availability 13 minutes ago 2026-01-15 20:08:12.497 9,000 5 hours ago 2026-01-15 15:17:12.378 10,000 6 hours ago 2026-01-15 14:13:17.246 9,000 8 hours ago 2026-01-15 11:38:53.236 15,000 12 hours ago 2026-01-15 07:58:45.477 25,000 18 hours ago 2026-01-15 02:09:42.074 15,000 1 day ago 2026-01-14 20:09:11.609 20,000 1 day ago 2026-01-14 17:29:06.242 30,000 1 day ago 2026-01-14 16:56:41.21 35,000 1 day ago 2026-01-14 14:14:43.854 20,000
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 7:47 PM
$NCEW Crazy setup 500k floater Low floater going crazy today This one has similar Setup as $SHPH Watching $PTHL $GNPX $MLEC too
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 7:35 PM
$NCEW Dont sleep on this has the $SHPH looks
0 · Reply
anonAlb
anonAlb Jan. 15 at 7:32 PM
$NCEW this baby is definitely the next🔥🔥🔥🚀🚀🚀🚀🚀 $SHPH $MLEC $CJMB 🌙🌙🌙🌙🌙🌙🌙
0 · Reply
PureTrades
PureTrades Jan. 15 at 7:30 PM
$SHPH $SUGP Why’d he sell at $7.40 then????
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 7:25 PM
$NCEW Crazy setup potential like $MLEC $SHPH
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 7:19 PM
$SUGP above 10$ here goeas parabolic like $SHPH
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 7:19 PM
$NCEW best setup in the market 500k floater Could pull a $MLEC $SHPH $CGTL Could pull a huge move soon
0 · Reply
lecorb
lecorb Jan. 15 at 5:30 PM
$SHPH Last update : now Time Since by Fintel Last Change Timestamp (UTC) US:SHPH Short Shares Availability 2 hours ago 2026-01-15 15:17:12.378 10,000 3 hours ago 2026-01-15 14:13:17.246 9,000 5 hours ago 2026-01-15 11:38:53.236 15,000 9 hours ago 2026-01-15 07:58:45.477 25,000 15 hours ago 2026-01-15 02:09:42.074 15,000 21 hours ago 2026-01-14 20:09:11.609 20,000 1 day ago 2026-01-14 17:29:06.242 30,000 1 day ago 2026-01-14 16:56:41.21 35,000 1 day ago 2026-01-14 14:14:43.854 20,000 1 day ago 2026-01-14 13:41:35.604 15,000
0 · Reply
lighthouse123
lighthouse123 Jan. 15 at 5:17 PM
$SHPH likely going to repeat what happened last Friday 🚀 1. Low float of 10,000 2. high borrowing cost > 89% $SUGP $SHPH $ROLR $SEGG $CJMB
1 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 4:22 PM
$SUGP Construction company like $SHPH 500k float crazy setup
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 3:23 PM
$SUGP $SHPH $ROLR SUGP about to breakout 🌋⏰️
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 3:16 PM
$SUGP $SHPH $ROLR SUGP about to leave the station
0 · Reply
lecorb
lecorb Jan. 15 at 3:06 PM
$SHPH Update Float: 1.57M 01/12/2026 Benzinga. -------Waiting for them to start the engines------------------------------------------ Last update : 16 minutes ago Time Since by Fintel. Last Change Timestamp (UTC) US:SHPH Short Shares Availability 48 minutes ago 2026-01-15 14:13:17.246 9,000 3 hours ago 2026-01-15 11:38:53.236 15,000 7 hours ago 2026-01-15 07:58:45.477 25,000 12 hours ago 2026-01-15 02:09:42.074 15,000 18 hours ago 2026-01-14 20:09:11.609 20,000 21 hours ago 2026-01-14 17:29:06.242 30,000 22 hours ago 2026-01-14 16:56:41.21 35,000 1 day ago 2026-01-14 14:14:43.854 20,000 1 day ago 2026-01-14 13:41:35.604 15,000 1 day ago 2026-01-14 11:07:34.98 10,000
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 3:05 PM
$SUGP $SHPH $ROLR $SEGG $CJMB SUGP HAS THE LOOKS ⏰️🌋
0 · Reply
SPARTANVI
SPARTANVI Jan. 15 at 2:59 PM
$SUGP Basically no walls here Above 7$ could be next $SHPH
0 · Reply